Self-Harm and Suicide

Self-harm is intentional self-injury regardless of motivation. It is the strongest predictor of completed suicide, with approximately 6,000 UK deaths by suicide annually.

Key Facts

Self-harm is the strongest risk factor for subsequent suicide — 50-100× increased risk in the year following self-harm Approximately 200,000 hospital presentations for self-harm annually in England; the true figure is much higher ~6,000 people die by suicide in the UK annually; M:F ~3:1 for completed suicide (F>M for self-harm) Self-poisoning (overdose) is the most common method of self-harm presenting to hospital (~80%) NICE CG16/NG225: All self-harm presentations should receive psychosocial assessment before discharge Risk assessment should be structured professional judgment — not based on checklists alone Means restriction (e.g., paracetamol pack size legislation, barriers at height) is the most effective population-level suicide prevention strategy Key risk factors: Previous self-harm, mental illness, substance misuse, social isolation, recent loss, male sex (for suicide)

Overview

Key Facts

Self-harm and suicide represent a spectrum of self-injurious behaviour. Self-harm is extremely common and is the strongest predictor of future suicide. Every self-harm presentation requires compassionate, thorough assessment.

Epidemiology

Self-harm is the most common reason for acute medical admission in women aged 15-24. Approximately 200,000 hospital attendances annually in England. Suicide rates: ~10 per 100,000 (UK); highest in men aged 45-49. Suicide is the leading cause of death in men under 50 in the UK.

Aetiology

Suicide risk factors:

  • Demographic: Male sex, age 45-54 (men), single/divorced, unemployed, social isolation
  • Psychiatric: Depression (most common), schizophrenia, bipolar disorder, personality disorder, substance misuse, eating disorders
  • Historical: Previous self-harm/attempt (strongest predictor), family history of suicide
  • Psychological: Hopelessness (strongest psychological predictor), impulsivity, poor problem-solving
  • Social: Recent loss, relationship breakdown, financial crisis, legal problems, bullying
  • Clinical: Recent psychiatric discharge (first 3 months), recent diagnosis of serious physical illness

Pathophysiology

  • Suicidal behaviour: Complex interaction of predisposing vulnerability, acute stressors, and reduced protective factors
  • Serotonergic dysfunction: Reduced CSF 5-HIAA associated with violent suicide attempts
  • Psychological models: Cry of Pain model (Williams), Interpersonal Theory of Suicide (Joiner — perceived burdensomeness + thwarted belongingness + acquired capability)
  • HPA axis dysregulation: Elevated cortisol, dexamethasone non-suppression associated with suicide risk

Clinical Presentation

Self-Harm Methods

  • Self-poisoning/overdose (~80%): Paracetamol (most common), NSAIDs, antidepressants, benzodiazepines
  • Self-cutting (~15-20%): Usually forearms, often superficial
  • Other: Hanging, burning, ingestion of foreign bodies, head-banging

Assessment of Intent

  • Was the act planned or impulsive?
  • Were precautions taken against discovery?
  • Was a suicide note written?
  • Were final acts performed (will, saying goodbye)?
  • What was the expected outcome — did they expect to die?
  • Was there help-seeking after the act?
  • What is the current mental state — ongoing suicidal ideation?

Red Flags for High Suicide Risk

  • Stated intent to die
  • Planned act with precautions against discovery
  • Violent method (hanging, jumping, firearms)
  • Male, middle-aged, living alone
  • Hopelessness persisting after assessment
  • Recent psychiatric discharge
  • Command hallucinations to harm self
  • Refusing assessment or treatment

Differential Diagnosis

PresentationAssessment FocusInvestigation
Self-harm with suicidal intentIntent, plan, ongoing ideationPsychosocial assessment
Self-harm without suicidal intentEmotional regulation, function of behaviourPsychosocial assessment
Paracetamol overdoseTime of ingestion, staggered vs singleParacetamol level at 4 hours, ALT, INR
Factitious self-injuryPattern, inconsistenciesClinical observation
Accidental injuryHistory, mechanismClinical assessment

Diagnosis / Investigation

Bedside

  • Psychosocial assessment: NICE CG16 — by trained professional before discharge
  • Risk assessment: Structured professional judgment (not validated checklist alone)
  • Mental state examination: Mood, hopelessness, psychosis, intoxication
  • Physical assessment: Treat medical consequences of self-harm first

Bloods (for overdose)

  • Paracetamol level: At 4 hours post-ingestion — plot on treatment nomogram
  • Salicylate level: If mixed overdose suspected
  • U&Es, LFTs, clotting (INR): Paracetamol hepatotoxicity
  • ECG: If TCA overdose or any cardiotoxic drug
  • Blood gas: Salicylate poisoning, TCA overdose

Special Tests

  • TOXBASE (National Poisons Information Service): Online resource for poisoning management
  • Drug levels: Lithium, digoxin, iron, carbamazepine — as indicated

Management

Non-pharmacological

  • Psychosocial assessment before discharge (NICE CG16) — every patient
  • Safety planning: Collaborative, personalised safety plan (NOT a 'no-suicide contract')
  • Follow-up: Within 48 hours of discharge from emergency department
  • Brief interventions: Safety planning intervention, problem-solving therapy
  • CBT: For recurrent self-harm; DBT for self-harm in BPD context
  • Means restriction counselling: Advise removal of medications, sharp objects from home

Pharmacological

  • Paracetamol overdose: N-acetylcysteine (NAC) IV per treatment protocol if level above treatment line
  • TCA overdose: Sodium bicarbonate 8.4% 50mL IV for QRS >100ms; avoid flumazenil
  • Treat underlying mental illness: Antidepressants (avoid TCAs if suicide risk — prescribe SSRIs), mood stabilisers, antipsychotics as indicated
  • Lithium: Reduces suicide risk by ~60% in bipolar disorder
  • Clozapine: Reduces suicidality in schizophrenia (InterSePT trial)

Referral Criteria

  • All self-harm presentations — psychosocial assessment (A&E liaison psychiatry)
  • Ongoing suicidal ideation — crisis team or inpatient admission
  • Recurrent self-harm — specialist psychology/psychiatry
  • Children and young people — CAMHS urgent assessment

Prognosis

  • 1-year repetition rate: ~15-25% after hospital-presenting self-harm
  • Lifetime suicide risk: ~3-7% following self-harm presentation
  • Highest risk period: First 3-6 months after self-harm episode
  • Paracetamol overdose: NAC is ~95% effective if given within 8 hours; mortality <0.5% with timely treatment
  • Means restriction: Paracetamol legislation (limiting pack size to 32 tablets) reduced paracetamol-related deaths by ~40%
  • Safety planning reduces repeat self-harm by ~50% compared to usual care

Other Relevant Information

SAD PERSONS Score (Mnemonic for Risk Factors)

FactorDetails
SexMale
Age<19 or >45
DepressionCurrent episode
Previous attemptStrongest predictor
Ethanol/drugsSubstance misuse
Rational thinking lossPsychosis
Social support lackingIsolation
Organised planDetailed plan
No partnerSingle/divorced
SicknessChronic physical illness

Paracetamol Overdose Key Facts

ParameterDetail
Toxic dose>75 mg/kg (>150 mg/kg = severe)
Level timing4 hours post-ingestion
TreatmentNAC if above treatment line
Peak liver damage72-96 hours
King's College criteriaFor transplant referral (pH <7.3, INR >6.5, creatinine >300, grade III/IV encephalopathy)